Psyence Biomedical Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PARALLEL ADVISORS, LLC | 06/03/2026 | 151.25 K | $574.75 K | 0.00% | 10.21% |
| STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD | 05/13/2026 | 89 | $218 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Psyence Biomedical Ltd. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Psyence Biomedical Ltd.. The most heavily invested institutionals were:
Parallel Advisors, LLC: 151,250
Stonehage Fleming Financial Services Holdings Ltd: 89
BANK OF AMERICA CORP /DE/: 0
Virtu Financial LLC: 0
UBS Group AG: 0
10.22% of Psyence Biomedical Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 151.34 K shares in the last 24 months. This purchase volume represents approximately $385.91 K in transactions.